JP2002521045A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002521045A5 JP2002521045A5 JP2000562052A JP2000562052A JP2002521045A5 JP 2002521045 A5 JP2002521045 A5 JP 2002521045A5 JP 2000562052 A JP2000562052 A JP 2000562052A JP 2000562052 A JP2000562052 A JP 2000562052A JP 2002521045 A5 JP2002521045 A5 JP 2002521045A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- base
- kvlqt1
- dna
- residue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9447798P | 1998-07-29 | 1998-07-29 | |
| US60/094,477 | 1998-07-29 | ||
| US09/135,010 | 1998-08-17 | ||
| US09/135,010 US6277978B1 (en) | 1995-12-22 | 1998-08-17 | KVLQT1—a long QT syndrome gene |
| PCT/US1999/010260 WO2000006199A1 (en) | 1998-07-29 | 1999-05-12 | Kvlqt1 - a long qt syndrome gene |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002521045A JP2002521045A (ja) | 2002-07-16 |
| JP2002521045A5 true JP2002521045A5 (https=) | 2006-07-13 |
Family
ID=26788931
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000562052A Pending JP2002521045A (ja) | 1998-07-29 | 1999-05-12 | Ｋｖｌｑｔ１−ｑｔ延長症候群 |
Country Status (8)
| Country | Link |
|---|---|
| US (5) | US6277978B1 (https=) |
| EP (1) | EP1100538B1 (https=) |
| JP (1) | JP2002521045A (https=) |
| AT (1) | ATE369420T1 (https=) |
| AU (1) | AU758048B2 (https=) |
| CA (1) | CA2336263A1 (https=) |
| DE (1) | DE69936781T2 (https=) |
| WO (1) | WO2000006199A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE366260T1 (de) * | 1996-09-11 | 2007-07-15 | Univ Oregon Health Sciences | Kalzium-aktivierte kaliumkanäle mit niedriger und mittlerer leitfähigkeit und ihre verwendungen. |
| ATE381626T1 (de) * | 2000-04-13 | 2008-01-15 | Univ Georgetown | Genetische diagnose zur feststellung von qt- verlängerungen als unerwünschte reaktion auf arzneimittel |
| TWI287984B (en) * | 2000-10-17 | 2007-10-11 | Wyeth Corp | Pharmaceutical composition for modulating bladder function |
| US20030162192A1 (en) * | 2001-08-20 | 2003-08-28 | Sotos John G. | Polymorphisms associated with ion-channel disease |
| JP2006511218A (ja) * | 2002-12-21 | 2006-04-06 | ファイザー・プロダクツ・インク | 薬物誘発性不整脈に関連する方法および組成物 |
| US7537928B2 (en) * | 2003-08-22 | 2009-05-26 | Masonic Medical Research Laboratory | Mutations in ion channel proteins associated with sudden cardiac death |
| US7833718B2 (en) * | 2006-11-06 | 2010-11-16 | Masonic Medical Research Laboratory | CACNA1C nucleic acid mutations as indicators of shorter than normal QT interval and ST segment elevation associated with sudden cardiac death |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0876491T3 (da) * | 1995-12-22 | 2009-07-06 | Univ Utah Res Found | Langt QT-syndrom-gen, der koder for KVLQT1 og dets association med minK |
| DK1007067T3 (da) | 1996-10-21 | 2002-05-06 | Eurovita As | Farmaceutiske præparater indeholdende Parthenium integrifolium eller dele deraf eller en ekstrakt bestanddel deraf, anvendelsen af et sådant plantemateriale til fremstilling af ... |
| BR9909110A (pt) | 1998-03-26 | 2000-12-12 | Phytopharm Plc | Usos de esmilagenina e anzurogenina d, compoisção farmacêutica tendo propriedades intensificadoras da função cognitiva, processo para intensificar a função cognitiva, e, composição para uso do mesmo |
| AUPP797598A0 (en) | 1998-12-30 | 1999-01-28 | Butters, Desley | Therapeutic agent |
| US6194469B1 (en) | 1998-12-11 | 2001-02-27 | Board Of Trustees Operating Michigan State Univeristy | Method for inhibiting cyclooxygenase and inflammation using cherry bioflavonoids |
| US20010006686A1 (en) | 1999-03-19 | 2001-07-05 | David G. Corley | Inflammatory mediation obtained from atractylodes lancea |
-
1998
- 1998-08-17 US US09/135,010 patent/US6277978B1/en not_active Expired - Lifetime
-
1999
- 1999-05-12 DE DE69936781T patent/DE69936781T2/de not_active Expired - Lifetime
- 1999-05-12 CA CA002336263A patent/CA2336263A1/en not_active Abandoned
- 1999-05-12 AT AT99922910T patent/ATE369420T1/de not_active IP Right Cessation
- 1999-05-12 WO PCT/US1999/010260 patent/WO2000006199A1/en not_active Ceased
- 1999-05-12 AU AU39800/99A patent/AU758048B2/en not_active Ceased
- 1999-05-12 JP JP2000562052A patent/JP2002521045A/ja active Pending
- 1999-05-12 EP EP99922910A patent/EP1100538B1/en not_active Expired - Lifetime
-
2000
- 2000-06-19 US US09/597,731 patent/US6582913B1/en not_active Expired - Lifetime
- 2000-06-19 US US09/597,735 patent/US6420124B1/en not_active Expired - Lifetime
- 2000-06-19 US US09/597,732 patent/US6451534B1/en not_active Expired - Lifetime
-
2003
- 2003-02-20 US US10/368,643 patent/US6972176B2/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4472173B2 (ja) | ５−リポキシゲナーゼ活性化タンパク（ｆｌａｐ）のゲノム配列、その多型マーカーおよび喘息の検出方法 | |
| Machida et al. | Transforming growth factor-α (TGFA): Genomic structure, boundary sequences, and mutation analysis in nonsyndromic cleft lip/palate and cleft palate only | |
| Li et al. | Melanocortin 3 receptor (MC3R) gene variants in extremely obese women | |
| JP2005130764A (ja) | Ｎａｒｃ−１遺伝子上の多型を利用した脂質代謝異常に起因する疾患の検査方法、および創薬のための用途 | |
| JP2003530814A5 (https=) | ||
| Collins et al. | The organization of the γ-glutamyl transferase genes and other low copy repeats in human chromosome 22q11 | |
| JP2002521065A5 (https=) | ||
| CA2336236A1 (en) | Mutations in and genomic structure of herg - a long qt syndrome gene | |
| CA2337491A1 (en) | Human mink gene mutations associated with arrhythmia | |
| CA2307316A1 (en) | Kcnq2 and kcnq3-potassium channel genes which are mutated in benign familial neonatal convulsions (bfnc) and other epilepsies | |
| JP2001514904A5 (https=) | ||
| Jirapongsananuruk et al. | CYBB mutation analysis in X-linked chronic granulomatous disease | |
| Roepman et al. | Identification of a gene disrupted by a microdeletion in a patient with X-linked retinitis pigmentosa (XLRP) | |
| Wong et al. | Detection of mitochondrial DNA mutations using temporal temperature gradient gel electrophoresis | |
| US20030129596A1 (en) | Chemical compounds | |
| JP2002521045A5 (https=) | ||
| Williams et al. | Comparative semi-automated analysis of (CAG) repeats in the Huntington disease gene: use of internal standards | |
| US20050233321A1 (en) | Identification of novel polymorphic sites in the human mglur8 gene and uses thereof | |
| CA2369812A1 (en) | Mink-related genes, formation of potassium channels and association with cardiac arrhythmia | |
| JP2009511026A (ja) | 血栓塞栓性及び冠状動脈性心疾患の診断方法 | |
| Haider et al. | Evaluation and molecular characterization of EHD1, a candidate gene for Bardet–Biedl syndrome 1 (BBS1) | |
| Nolsøe et al. | Complete mutation scan of the human Fas ligand gene: linkage studies in Type I diabetes mellitus families | |
| JP4111481B2 (ja) | 心筋梗塞の遺伝的要因を判定するための方法及びこれに使用されるオリゴヌクレオチド | |
| CN1764728A (zh) | 猪的多态性及其检测方法 | |
| Kamio et al. | Direct determination of MUC5B promoter haplotypes based on the method of single-strand conformation polymorphism and their statistical estimation |